Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Holiday Inn London Kensington Forum

Oct 17, 2017 12:30 PM - Oct 18, 2017 5:00 PM

97 Cromwell Road, London, SW7 4DN, United Kingdom

A Comprehensive Review of Regulatory Procedures for New Drug Applications in the US

ONLY 5 SEATS LEFT! This course will enhance understanding and be beneficial to persons who work in clinical research, data management, biostatistics, basic research, project management and marketing.

SESSION 7: INTERACTIONS WITH FDA

Session Chair(s)

Carol H. Danielson, DrPH, MS, RAC

Carol H. Danielson, DrPH, MS, RAC

President

Regulatory Advantage, LLC, United States

Michael  Hamrell, PHD, RAC

Michael Hamrell, PHD, RAC

President

MORIAH Consultants, United States

  • FDA's guidance on meetings and how to request them
  • Time course of events in requesting a meeting
  • Objectives and conduct of specific meetings with FDA
  • Principles for communicating with FDA
  • Meeting etiquette
  • How to resolve issues or disputes with FDA
  • Summary on interacting with FDA advisory committee meetings

Speaker(s)

Carol H. Danielson, DrPH, MS, RAC

INTERACTIONS WITH FDA

Carol H. Danielson, DrPH, MS, RAC

Regulatory Advantage, LLC, United States

President

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.